1000 related articles for article (PubMed ID: 27581702)
1. Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients.
Simrén M; Palsson OS; Heymen S; Bajor A; Törnblom H; Whitehead WE
Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27581702
[TBL] [Abstract][Full Text] [Related]
2. Irritable Bowel Syndrome and Quality of Life in Women With Fecal Incontinence.
Markland AD; Jelovsek JE; Rahn DD; Wang L; Merrin L; Tuteja A; Richter HE; Meikle S;
Female Pelvic Med Reconstr Surg; 2017; 23(3):179-183. PubMed ID: 27918339
[TBL] [Abstract][Full Text] [Related]
3. Fecal incontinence in people with self-reported irritable bowel syndrome: Prevalence and quality of life.
Hunt MG; Wong C; Aajmain S; Dawodu I
J Psychosom Res; 2018 Oct; 113():45-51. PubMed ID: 30190047
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome.
Goodoory VC; Ng CE; Black CJ; Ford AC
Aliment Pharmacol Ther; 2023 May; 57(10):1083-1092. PubMed ID: 36914979
[TBL] [Abstract][Full Text] [Related]
5. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and Factors Associated With Fecal Incontinence: Results From a Population-Based Survey.
Menees SB; Almario CV; Spiegel BMR; Chey WD
Gastroenterology; 2018 May; 154(6):1672-1681.e3. PubMed ID: 29408460
[TBL] [Abstract][Full Text] [Related]
7. Co-occurrence of fecal incontinence with constipation or irritable bowel syndrome indicates the need for personalized treatment.
Sun G; Trzpis M; Ding H; Gao X; Broens PMA; Zhang W
Neurogastroenterol Motil; 2023 Sep; 35(9):e14633. PubMed ID: 37427541
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of functional bowel disorders and faecal incontinence: an Australian primary care survey.
Ng KS; Nassar N; Hamd K; Nagarajah A; Gladman MA
Colorectal Dis; 2015 Feb; 17(2):150-9. PubMed ID: 25359460
[TBL] [Abstract][Full Text] [Related]
9. Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age.
Thakur ER; Quigley BM; El-Serag HB; Gudleski GD; Lackner JM
J Psychosom Res; 2016 Sep; 88():48-53. PubMed ID: 27521653
[TBL] [Abstract][Full Text] [Related]
10. Association between bowel symptoms, symptom severity, and quality of life in Swedish patients with fecal incontinence.
Walter S; Hjortswang H; Holmgren K; Hallböök O
Scand J Gastroenterol; 2011 Jan; 46(1):6-12. PubMed ID: 20735152
[TBL] [Abstract][Full Text] [Related]
11. Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem.
Frändemark Å; Törnblom H; Jakobsson S; Simrén M
Am J Gastroenterol; 2018 Oct; 113(10):1540-1549. PubMed ID: 30254230
[TBL] [Abstract][Full Text] [Related]
12. Faecal incontinence-the hidden scourge of irritable bowel syndrome: a cross-sectional study.
Atarodi S; Rafieian S; Whorwell PJ
BMJ Open Gastroenterol; 2014; 1(1):e000002. PubMed ID: 26462260
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
Buono JL; Carson RT; Flores NM
Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
[TBL] [Abstract][Full Text] [Related]
14. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
[TBL] [Abstract][Full Text] [Related]
15. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
Aziz I; Törnblom H; Palsson OS; Whitehead WE; Simrén M
Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
[TBL] [Abstract][Full Text] [Related]
16. Irritable bowel syndrome, mental health, and quality of life: Data from a population-based survey in Germany (SHIP-Trend-0).
Schauer B; Grabe HJ; Ittermann T; Lerch MM; Weiss FU; Mönnikes H; Völzke H; Enck P; Schwille-Kiuntke J
Neurogastroenterol Motil; 2019 Mar; 31(3):e13511. PubMed ID: 30444067
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of irritable bowel syndrome: Symptom development over a 3-year period in Denmark. A prospective, population-based cohort study.
Krogsgaard LR; Engsbro AL; Jones MP; Bytzer P
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27865035
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria.
Long Y; Huang Z; Deng Y; Chu H; Zheng X; Yang J; Zhu Y; Fried M; Fox M; Dai N
Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27412422
[TBL] [Abstract][Full Text] [Related]
19. Shared Risk Factors for Constipation, Fecal Incontinence, and Combined Symptoms in Older U.S. Adults.
Andy UU; Vaughan CP; Burgio KL; Alli FM; Goode PS; Markland AD
J Am Geriatr Soc; 2016 Nov; 64(11):e183-e188. PubMed ID: 27783401
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
